Join Us
WHO WE ARE · HOW WE WORK · WHAT WE STAND FOR
We give physicians cellular vision.
Come help us.
Mauna Kea Technologies builds Cellvizio® — real-time, in vivo cellular imaging that lets doctors see living cells inside the body, and decide in the moment. The science is hard. The people are the reason it works.
OUR PURPOSE
Improving patient lives by empowering physicians with cellular vision.
We are building a company with no easy answers. Markets shift, science evolves, and there is no instruction manual for a MedTech company that sets out to change the world.
What carries us through that uncertainty is a shared way of working — and a clear line of sight to why it matters: a surgery avoided, a cancer caught early, a remission that can finally be measured.
What we do is who we are.
Sacha Loiseau — Founder & CEO
OUR IMPACT
Small team. Outsized footprint.
patient lives changed
1,300+
clinical papers
800+
systems installed
270+
patents
60+
MKTers, across Paris & Boston
The field keeps seeing things first through Cellvizio®.
01
Neurons, in vivo — first visualization in living, moving mice.
02
The alveoli of the lung — first in vivo visualization.
03
Pancreatic cystic lesions — first in vivo microscopic visualization.
04
The interstitium — first visualization of the bile-duct epithelium, and a discovery the New York Times featured in 2026 as one that could link Eastern and Western medicine.
HOW WE WORK
Three values. One way of working.
Strategy is what we plan; culture is what actually happens when no one is watching. These are the people we choose to be — and the people we want to work alongside.
LIGHT THE WAY
We are driven by the desire to make things better.
Progress over perfection
Positive bias High standards
Curiosity
TAKE THE LEAD
We step up and take responsibility.
SUCCEED TOGETHER
We succeed as one team.
News
YOU MIGHT ALSO LIKE TO READ
Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth
Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity
Mauna Kea Technologies Secures €4.0M Shareholder Loan Agreement to Strengthen Liquidity and Fund Organic Growth
Find out more by downloading the
Cellvizio Brochure